Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$20.9B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

STERIS plc is a leading provider of health care equipment and services, focusing on sterilization and infection prevention solutions. Operating in the health care sector, the company plays a critical role in ensuring patient safety and improving operational efficiency in medical facilities.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$2.85

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and drive sales, which is crucial for sustaining long-term growth.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, declining by 2.70% the following day.

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to innovation in health care solutions.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Overall, expectations are mixed as STERIS approaches its earnings report. Investors are looking for signs of recovery in revenue growth after a slight EPS miss last quarter.

Bull Case

If STERIS can exceed EPS estimates and show strong revenue growth, it may signal a turnaround in operational performance and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its long-term growth prospects and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$2.85

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market presence and drive sales, which is crucial for sustaining long-term growth.

Operating Margin

N/A

Operating margin indicates the efficiency of the company's operations and its ability to manage costs relative to revenue.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to the previous quarter?

The EPS figure will be crucial in assessing whether the company is on track to recover from its recent miss and regain investor confidence.

What are the expectations for revenue growth in the upcoming quarter?

Revenue growth is a key indicator of the company's market performance and ability to expand, which will be closely scrutinized by investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's potential for a rebound in operational efficiency and revenue growth due to recent investments in innovation.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% success rate over the last eight quarters.

Options pricing suggests a significant move, indicating that investors are anticipating a potential surprise.

Insider buying activity suggests confidence in the company's future performance.

Key Risk

If revenue growth exceeds expectations, it could invalidate the cautious outlook currently priced in by the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows a slight miss last quarter, and investors are eager to see if STERIS can rebound.

Bull Confirmed If

An EPS of $2.85 or higher, alongside positive revenue growth, would confirm the bull case.

Bear Confirmed If

An EPS below $2.80 would raise concerns about the company's growth trajectory and operational efficiency.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a positive reaction, potentially around +0.99% on the first day.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors digest the commentary.

Miss

If STERIS misses EPS expectations again, the stock could decline, with historical averages suggesting a move of around -0.85%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in health care solutions.
2Management's outlook on revenue growth and operational efficiency.
3Details on cost management strategies and their impact on margins.
4Insights into customer demand trends and market conditions.
5Any commentary on competitive positioning within the health care equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$2.85

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and drive sales, which is crucial for sustaining long-term growth.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, declining by 2.70% the following day.

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to innovation in health care solutions.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Overall, expectations are mixed as STERIS approaches its earnings report. Investors are looking for signs of recovery in revenue growth after a slight EPS miss last quarter.

Bull Case

If STERIS can exceed EPS estimates and show strong revenue growth, it may signal a turnaround in operational performance and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its long-term growth prospects and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$2.85

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market presence and drive sales, which is crucial for sustaining long-term growth.

Operating Margin

N/A

Operating margin indicates the efficiency of the company's operations and its ability to manage costs relative to revenue.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to the previous quarter?

The EPS figure will be crucial in assessing whether the company is on track to recover from its recent miss and regain investor confidence.

What are the expectations for revenue growth in the upcoming quarter?

Revenue growth is a key indicator of the company's market performance and ability to expand, which will be closely scrutinized by investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's potential for a rebound in operational efficiency and revenue growth due to recent investments in innovation.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% success rate over the last eight quarters.

Options pricing suggests a significant move, indicating that investors are anticipating a potential surprise.

Insider buying activity suggests confidence in the company's future performance.

Key Risk

If revenue growth exceeds expectations, it could invalidate the cautious outlook currently priced in by the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows a slight miss last quarter, and investors are eager to see if STERIS can rebound.

Bull Confirmed If

An EPS of $2.85 or higher, alongside positive revenue growth, would confirm the bull case.

Bear Confirmed If

An EPS below $2.80 would raise concerns about the company's growth trajectory and operational efficiency.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a positive reaction, potentially around +0.99% on the first day.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors digest the commentary.

Miss

If STERIS misses EPS expectations again, the stock could decline, with historical averages suggesting a move of around -0.85%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in health care solutions.
2Management's outlook on revenue growth and operational efficiency.
3Details on cost management strategies and their impact on margins.
4Insights into customer demand trends and market conditions.
5Any commentary on competitive positioning within the health care equipment sector.